SKI Market

Indian Indices

Nifty

25,839.65 -120.90
(-0.47%)

Sensex

84,666.28 -436.41
( -0.51%)

Bank Nifty

59,222.35 -16.20
( -0.03%)

Nifty IT

38,130.60 -460.10
( -1.19%)

Global Indices

Nasdaq

47,765.34 -210.65
(-0.44%)

Dow Jones

6,868.55 -22.85
(-0.33%)

Hang Seng

50,689.00 107.06
(0.21%)

Nikkei 225

9,640.52 -4.57
(-0.05%)

Forex

USD-INR

89.90 -0.09
(-0.10%)

EUR-INR

104.66 -0.26
(-0.25%)

GBP-INR

119.79 -0.26
(-0.22%)

JPY-INR

0.58 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Gennex Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

531739

INE509C01026

8.6694335

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

21.52

313.65

EPS(TTM)

Face Value()

Div & Yield %

0.6

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	105.11	74.05	71.35	65.26	63.65	59.96
Excise Duty	10.53	7.25	6.25	4.05	4.00	4.34
Net Sales	94.58	66.80	65.10	61.21	59.65	55.62
Other Income	9.22	4.30	3.40	1.38	0.52	1.06
Stock Adjustments	0.70	2.44	7.00	1.91	-1.53	1.51
Total Income	104.50	73.54	75.50	64.50	58.64	58.19
EXPENDITURE :
Raw Materials	68.36	41.94	48.14	41.23	35.18	36.20
Power & Fuel Cost	3.08	3.29	4.26	3.17	3.01	3.30
Employee Cost	6.42	6.05	7.71	6.97	7.21	6.81
Other Manufacturing Expenses	0.77	1.06	1.18	0.80	2.14	3.67
Selling & Administrative Expenses	4.72	2.93	4.40	3.43	3.44	3.34
Miscellaneous Expenses	1.74	1.54	1.82	2.15	0.98	0.56
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	85.08	56.81	67.51	57.74	51.96	53.88
Operating Profit	19.41	16.73	7.99	6.76	6.68	4.30
Interest	1.58	1.16	1.23	0.88	0.74	0.75
Gross Profit	17.83	15.57	6.76	5.88	5.94	3.55
Depreciation	0.77	0.81	0.74	0.79	0.88	1.00
Profit Before Tax	17.06	14.76	6.02	5.09	5.06	2.55
Tax	2.97	3.05	1.59	1.32	1.27	0.85
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.05	-0.09	-0.14	-0.15	-0.25	-0.16
Reported Net Profit	14.04	11.80	4.56	3.92	4.04	1.86
Extraordinary Items	-0.14	0.00	0.04	0.00	-0.28	0.08
Adjusted Net Profit	14.18	11.80	4.52	3.92	4.32	1.78
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	40.02	28.22	23.66	19.74	15.70	13.84
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	54.05	40.02	28.22	23.66	19.74	15.70
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	0.62	0.52	0.25	0.31	0.32	0.15
Earnings Per Share(Adj)-Unit Curr	0.62	0.52	0.25	0.30	0.31	0.14
Book Value-Unit Curr	7.87	7.26	4.39	3.48	3.15	2.83
Book Value(Adj)-Unit Curr	7.87	7.26	4.39	3.32	3.00	2.69

25,839.65 -120.90 (-0.47%)

84,666.28 -436.41 ( -0.51%)

59,222.35 -16.20 ( -0.03%)

38,130.60 -460.10 ( -1.19%)

47,765.34 -210.65 (-0.44%)

6,868.55 -22.85 (-0.33%)

50,689.00 107.06 (0.21%)

9,640.52 -4.57 (-0.05%)

89.90 -0.09 (-0.10%)

104.66 -0.26 (-0.25%)

119.79 -0.26 (-0.22%)

0.58 0.00 (-0.32%)